Mobile Site ›

Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation

An Update



Subscribe

Receive notification when new Hot Topics are published:

Summary

Slide 18

April 2012

In summary, the autoimmune gastrointestinal dysmotility serological evaluation aids the investigation of new onset idiopathic gastrointestinal dysmotility. Detection of 1 or more of this profile of autoantibodies may lead to detection of unsuspected cancer and seropositivity will indicate a potentially immunotherapy responsive disorder.

Summary

 


Jump to section:


Key